Cell-Free DNA Concentration in Pleural Fluid and Serum: Quantitative Approach and Potential Prognostic Factor in Patients with Cancer and Pleural Effusions
Authors:
- Susana BenllochSBSusana Benlloch
- Juan Luis Martí-CiriquiánJMJuan Luis Martí-Ciriquián
- José Marcelo Galbis-CaravajalJGJosé Marcelo Galbis-Caravajal
- Concepción MartínCMConcepción Martín
- José Sánchez-PayáJSJosé Sánchez-Payá
- José Manuel Rodríguez-PaniaguaJRJosé Manuel Rodríguez-Paniagua
- Santiago RomeroSRSantiago Romero
- Bartomeu MassutíBMBartomeu Massutí
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 8 (2) , 140-145
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Early Detection of Lung Cancer Using Serum RNA or DNA Markers: Ready for “Prime Time” or for Validation?Journal of Clinical Oncology, 2003
- Quantification of Free Circulating DNA As a Diagnostic Marker in Lung CancerJournal of Clinical Oncology, 2003
- Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patientsCancer Letters, 2003
- Management of Malignant Pleural EffusionsAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusionsBritish Journal of Cancer, 1999
- Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid: A study of 207 patientsCancer, 1996
- Evolution of Idiopathic Pleural EffusionChest, 1996
- CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusionsEuropean Respiratory Journal, 1996
- The PleuraAmerican Review of Respiratory Disease, 1988
- Determination of circulating DNA levels in patients with benign or malignant gastrointestinal diseaseCancer, 1983